4.6 Article

A Chemical Analog of Curcumin as an Improved Inhibitor of Amyloid Abeta Oligomerization

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention

Kevin A. DaSilva et al.

EXPERIMENTAL NEUROLOGY (2010)

Article Neurosciences

Why Pleiotropic Interventions are Needed for Alzheimer's Disease

Sally A. Frautschy et al.

MOLECULAR NEUROBIOLOGY (2010)

Review Clinical Neurology

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)

Article Biotechnology & Applied Microbiology

Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease

Philip Thomas et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)

Article Biotechnology & Applied Microbiology

Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells

Leonardo Meneghin Mendonca et al.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2009)

Review Psychology, Clinical

Beta-Amyloid Deposition and the Aging Brain

Karen M. Rodrigue et al.

NEUROPSYCHOLOGY REVIEW (2009)

Editorial Material Pharmacology & Pharmacy

Curcumin as Curecumin:: From kitchen to clinic

Ajay Goel et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Review Pharmacology & Pharmacy

Amyloid beta-Protein Assembly as a Therapeutic Target of Alzheimer's Disease

Ghiam Yamin et al.

CURRENT PHARMACEUTICAL DESIGN (2008)

Letter Pharmacology & Pharmacy

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

Larry Baum et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)

Article Pharmacology & Pharmacy

Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease

Aynun N. Begum et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)

Review Medicine, Research & Experimental

Bioavailability of curcumin: Problems and promises

Preetha Anand et al.

MOLECULAR PHARMACEUTICS (2007)

Article Chemistry, Medicinal

Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Aβ fibril formation

Seong Rim Byeon et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Biochemistry & Molecular Biology

Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro

Celine Riviere et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2007)

Review Chemistry, Medicinal

Disrupting beta-amyloid aggregation for Alzheimer disease treatment

L. D. Estrada et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)

Article Public, Environmental & Occupational Health

Curry consumption and cognitive function in the elderly

Tze-Pin Ng et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)

Article Biochemistry & Molecular Biology

Anti-oxidant activities of curcumin and related enones

WM Weber et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo

FS Yang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Review Oncology

Curcumin: The story so far

RA Sharma et al.

EUROPEAN JOURNAL OF CANCER (2005)

Article Neurosciences

Curcumin has potent anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro

K Ono et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2004)

Article Biochemical Research Methods

Alzheimer's β-peptide oligomer formation at physiologic concentrations

H LeVine

ANALYTICAL BIOCHEMISTRY (2004)

Article Medicine, General & Internal

Memantine in moderate-to-severe Alzheimer's disease

B Reisberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Biotechnology & Applied Microbiology

Therapeutic strategies for human amyloid diseases

JC Sacchettini et al.

NATURE REVIEWS DRUG DISCOVERY (2002)

Article Geriatrics & Gerontology

Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology

SA Frautschy et al.

NEUROBIOLOGY OF AGING (2001)

Review Biochemistry & Molecular Biology

Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis

MD Kirkitadze et al.

JOURNAL OF MOLECULAR BIOLOGY (2001)

Review Cell Biology

Determinants of passive drug entry into the central nervous system

MD Habgood et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)